These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18803843)

  • 1. Survival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients.
    Stigliano V; Assisi D; Cosimelli M; Palmirotta R; Giannarelli D; Mottolese M; Mete LS; Mancini R; Casale V
    J Exp Clin Cancer Res; 2008 Sep; 27(1):39. PubMed ID: 18803843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of survival between patients with hereditary non polyposis colorectal cancer (HNPCC) and sporadic colorectal cancer.
    Haghighi MM; Vahedi M; Mohebbi SR; Pourhoseingholi MA; Fatemi SR; Zali MR
    Asian Pac J Cancer Prev; 2009; 10(2):209-12. PubMed ID: 19537885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of patients with Stage III colon cancer is improved in hereditary non-polyposis colorectal cancer compared with sporadic cases. A Danish registry based study.
    Brixen LM; Bernstein IT; Bülow S; Ehrnrooth E
    Colorectal Dis; 2013 Jul; 15(7):816-23. PubMed ID: 23350633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of patients with hereditary colorectal cancer: comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer.
    Bertario L; Russo A; Sala P; Eboli M; Radice P; Presciuttini S; Andreola S; Rodriguez-Bigas MA; Pizzetti P; Spinelli P
    Int J Cancer; 1999 Jan; 80(2):183-7. PubMed ID: 9935197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer risk and overall survival in mismatch repair proficient hereditary non-polyposis colorectal cancer, Lynch syndrome and sporadic colorectal cancer.
    Garre P; Martín L; Bando I; Tosar A; Llovet P; Sanz J; Romero A; de la Hoya M; Díaz-Rubio E; Caldés T
    Fam Cancer; 2014 Mar; 13(1):109-19. PubMed ID: 24061861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary non-polyposis colorectal cancer: clinical features and survival. Results from the Danish HNPCC register.
    Myrhøj T; Bisgaard ML; Bernstein I; Svendsen LB; Søndergaard JO; Bülow S
    Scand J Gastroenterol; 1997 Jun; 32(6):572-6. PubMed ID: 9200290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members.
    Watson P; Lin KM; Rodriguez-Bigas MA; Smyrk T; Lemon S; Shashidharan M; Franklin B; Karr B; Thorson A; Lynch HT
    Cancer; 1998 Jul; 83(2):259-66. PubMed ID: 9669808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of colorectal cancer varies in different high-risk conditions.
    Aarnio M; Mustonen H; Mecklin JP; Järvinen HJ
    Ann Med; 1998 Feb; 30(1):75-80. PubMed ID: 9556092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative serum levels of the carcinoembryonic antigen in hereditary non-polyposis colorectal cancer compared to levels in sporadic colorectal cancer.
    Schiemann U; Günther S; Gross M; Henke G; Müller-Koch Y; König A; Muders M; Folwaczny C; Mussack T; Holinski-Feder E
    Cancer Detect Prev; 2005; 29(4):356-60. PubMed ID: 16122885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival from colorectal carcinoma in HNPCC families as compared to the general population in Lithuania--initial results.
    Elsakov P; Kurtinaitis J
    Fam Cancer; 2006; 5(4):369-71. PubMed ID: 16826317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
    Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
    Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inverse effects of mucin on survival of matched hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer patients.
    You JF; Hsieh LL; Changchien CR; Chen JS; Chen JR; Chiang JM; Yeh CY; Hsieh PS; Fan CW; Liu CT; Tang R
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4244-50. PubMed ID: 16857798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of patients with ovarian cancer due to a mismatch repair defect.
    Crijnen TE; Janssen-Heijnen ML; Gelderblom H; Morreau J; Nooij MA; Kenter GG; Vasen HF
    Fam Cancer; 2005; 4(4):301-5. PubMed ID: 16341807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Registration of hereditary non-polyposis colorectal cancer].
    Bernstein IT; Bisgaard ML; Myrhøj T
    Ugeskr Laeger; 1999 Nov; 161(45):6174-8. PubMed ID: 10603753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance improves survival of colorectal cancer in patients with hereditary nonpolyposis colorectal cancer.
    Renkonen-Sinisalo L; Aarnio M; Mecklin JP; Järvinen HJ
    Cancer Detect Prev; 2000; 24(2):137-42. PubMed ID: 10917133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer.
    Shia J; Ellis NA; Paty PB; Nash GM; Qin J; Offit K; Zhang XM; Markowitz AJ; Nafa K; Guillem JG; Wong WD; Gerald WL; Klimstra DS
    Am J Surg Pathol; 2003 Nov; 27(11):1407-17. PubMed ID: 14576473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.
    Johnson V; Volikos E; Halford SE; Eftekhar Sadat ET; Popat S; Talbot I; Truninger K; Martin J; Jass J; Houlston R; Atkin W; Tomlinson IP; Silver AR
    Gut; 2005 Feb; 54(2):264-7. PubMed ID: 15647192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of survival between patients with hereditary non polyposis colorectal cancer (HNPCC) and sporadic colorectal cancer.
    Haghighi MM; Vahedi M; Mohebbi SR; Pourhoseingholi MA; Fatemi SR; Zali MR
    Asian Pac J Cancer Prev; 2009; 10(3):497-500. PubMed ID: 19640198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Better survival rates in patients with MLH1-associated hereditary colorectal cancer.
    Sankila R; Aaltonen LA; Järvinen HJ; Mecklin JP
    Gastroenterology; 1996 Mar; 110(3):682-7. PubMed ID: 8608876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The correlation of microsatellite instability and tumor-infiltrating lymphocytes in hereditary non-polyposis colorectal cancer (HNPCC) and sporadic colorectal cancers: the significance of different types of lymphocyte infiltration.
    Takemoto N; Konishi F; Yamashita K; Kojima M; Furukawa T; Miyakura Y; Shitoh K; Nagai H
    Jpn J Clin Oncol; 2004 Feb; 34(2):90-8. PubMed ID: 15067103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.